Search
Menu
Home
HTB
2004
November
HTB
November 2004
Contents
Conference reports
XV International World AIDS Conference, 11-16 July 2004, Bangkok
Women and HIV: research directions
The X4 files: sampling the science on HIV co-receptors in Bangkok
10th BHIVA Autumn Conference 8-9 October 2004, London
BHIVA audit on management of HIV/Hepatitis coinfection
Antiretrovirals
Six generics compare well with US-made ARVs
Viral load response at 4 weeks predicts treatment success
Resistance mutations in patients with persistent viraemia show need to improve clinical assays
Researchers call for new approach to assessing pipeline drugs for salvage patients
Treatment access
A round-up of news about access to treatments with links to sources: Britain, Ukraine, Thailand, Europe, South Africa
Body Mass Index at diagnosis is independent predictor of survival
Pregnancy
Study raises questions about cost effectiveness of nevirapine regimen
Low effectiveness of nevirapine to reduce MTCT in real life situation
Use of T-20 at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough
Paediatric care
CHIPS data finds response to HAART varies with age in children
HAART is effective in African children in a resource-limited setting
Predictive factors of virologic success in HIV positive children treated with lopinavir/ritonavir
Side effects
Vancouver researchers urge caution with combinations of lipid drugs
Coinfections and complications
Clinical features and predictors of survival in patients with AIDS-related non-Hodgkin’s lymphoma
Hepatitis coinfection
3TC resistance leads to hepatitis B flare
Sight changes reported with PEG-interferon
BMS submits marketing applications for entecavir to treat HBV in US and Europe
Other news
Dispersal of HIV-positive asylum seekers: national survey of UK healthcare providers
Medical journals require pre-trial registration in public database as criteria for submission for publication
On the web
Conference abstracts and reports
Online medical education
Hepatitis coinfection
PDFs
Volume 5 Number 9/10 October/November 2004 PDF
HTB RSS
Early access
Lenacapavir submitted to the US FDA with an indication for HIV PrEP
20 December 2024
i-Base guides updated online
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate